Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Andrew A. Lane, MD, PhD, Diederik van Bodegom, PhD, Bjoern Chapuy, MD, PhD, Gabriela Alexe, PhD, Timothy J Sullivan, PhD, Trevor Tivey, Tovah Day, PhD, John Crispino, PhD, Edward Fox, PhD, Kimberly Stegmaier, MD, David Weinstock, MD

Blood (2012) 120 (21): 115.

https://doi.org/10.1182/blood.V120.21.115.115

Published: 2012

Journal Articles

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

Richard M. Stone, MD, Caitlin Driscoll, Ilene Galinsky, ANP, Martha Wadleigh, MD, David P. Steensma, MD, David Avigan, MD, Philip C. Amrein, MD, Suiyang Liu, James D. Griffin, MD, Steven L. McAfee, MD, Eyal C. Attar, MD, Karen K. Ballen, MD, Edward Fox, PhD, Daniel J. DeAngelo, MD, PhD

Blood (2012) 120 (21): 3627.

https://doi.org/10.1182/blood.V120.21.3627.3627

Published: 2012

Journal Articles

Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation,

Oliver Weigert, MD, Nadja Kopp, Andrew A. Lane, MD, PhD, Akinori Yoda, PhD, Suzanne E. Dahlberg, PhD, Donna Neuberg, ScD, Anita Y Bahar, Bjoern Chapuy, MD, PhD, Frank Kuo, MD, PhD, Terry Haley, PhD, Timothy J Sullivan, Edward Fox, PhD, Scott J. Rodig, MD, PhD, Joseph H Antin, MD, David M Weinstock, MD

Blood (2011) 118 (21): 3671.

https://doi.org/10.1182/blood.V118.21.3671.3671

Published: 2011

Journal Articles

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

Sophia Adamia, Ph.D, Michal Bar-Natan, M.D, Benjamin Haibe-Kains, Ph.D, Hervé Avet-Loiseau, MD, PhD, Laurence Lode, Ph.D, Samuel Pevzner, Sigitas Verselis, PhD, Edward Fox, PhD, Ilene Galinsky, ANP, John Quackenbush, Ph.D, Richard M. Stone, MD, James D Griffin, MD

Blood (2011) 118 (21): 761.

https://doi.org/10.1182/blood.V118.21.761.761

Published: 2011

Journal Articles

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Guang Yang, MD, Christina Hanzis, Sigitas Verselis, PhD, Lian Xu, Zachary Hunter, Leukothea Ioakimidis, Patricia Sheehy, NP, Christopher Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2010) 116 (21): 4904.

https://doi.org/10.1182/blood.V116.21.4904.4904

Published: 2010

Journal Articles

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Evdoxia Hatjiharissi, MD, Daniel Ditzel Santos, MD, Lian Xu, Sigitas Verselis, PhD, Michael Modica, PhD, Xavier Leleu, MD, Zachary Hunter, Allen W. Ho, Robert Manning, Christopher Patterson, Kenneth C. Anderson, MD, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 776.

https://doi.org/10.1182/blood.V106.11.776.776

Published: 2005

Journal Articles

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Evdoxia Hatjiharissi, MD, Mark Hansen, Sigitas Verselis, PhD, Daniel Ditzel Santos, MD, Lian Xu, Robert Manning, Zachary Hunter, Xavier Leleu, MD, Allen W. Ho, Christopher J. Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 2433.

https://doi.org/10.1182/blood.V106.11.2433.2433

Published: 2005

NARROW

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation,

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Email alerts

ASH Publications

American Society of Hematology

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation,

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only